doi: 10.1002/vms3.1057.
- PMID: 37002652
- DOI: 10.1002/vms3.1057
Free article
Abstract
A 10-year-old mixed breed male cat presented with clinical signs related to chronic orthopaedic pain. Upon physical examination, pain was noted, based on the feline Musculoskeletal Pain Index (FMPI). An analgesic treatment with a full spectrum cannabis oil (1.8% CBD and 0.8% THC) was proposed for 30 days (0,5 mg/kg based on CBD). The FMPI scale score decreased more than 50%. This case reported a satisfactory outcome for the patient and the owner, although this medication could increase ALT. Given the paucity of literature published to date on the treatment of veterinary species with cannabis-based medications, further clinical and pharmacokinetic studies are necessary to study the safety and efficacy of its use.
Keywords: cannabidiol; cannabis; chronic pain; osteoarthritis; tetrahydrocannabinol.
© 2022 The Authors. Veterinary Medicine and Science published by John Wiley & Sons Ltd.
Similar articles
-
An experimental randomized study on the analgesic effects of pharmaceutical-grade cannabis in chronic pain patients with fibromyalgia.Pain. 2019 Apr;160(4):860-869. doi: 10.1097/j.pain.0000000000001464.PMID: 30585986 Free PMC article. Clinical Trial.
-
A Randomized, Triple-Blind, Comparator-Controlled Parallel Study Investigating the Pharmacokinetics of Cannabidiol and Tetrahydrocannabinol in a Novel Delivery System, Solutech, in Association with Cannabis Use History.Cannabis Cannabinoid Res. 2022 Dec;7(6):777-789. doi: 10.1089/can.2021.0176. Epub 2022 Jul 5.PMID: 35787693 Free PMC article. Clinical Trial.
-
Pilot clinical and pharmacokinetic study of Δ9-Tetrahydrocannabinol (THC)/Cannabidiol (CBD) nanoparticle oro-buccal spray in patients with advanced cancer experiencing uncontrolled pain.PLoS One. 2022 Oct 14;17(10):e0270543. doi: 10.1371/journal.pone.0270543. eCollection 2022.PMID: 36240167 Free PMC article.
-
The anti-inflammatory and analgesic effects of formulated full-spectrum cannabis extract in the treatment of neuropathic pain associated with multiple sclerosis.Inflamm Res. 2020 Jun;69(6):549-558. doi: 10.1007/s00011-020-01341-1. Epub 2020 Apr 1.PMID: 32239248 Review.
-
Cannabis-based medicines–GW pharmaceuticals: high CBD, high THC, medicinal cannabis–GW pharmaceuticals, THC:CBD.Drugs R D. 2003;4(5):306-9. doi: 10.2165/00126839-200304050-00005.PMID: 12952500 Review.
References
REFERENCES
-
- Benito, J., Hansen, B., DePuy, V., Davidson, G. S., Thomson, A., Simpson, W., Roe, S., Hardie, E., & Lascelles, B. D. X. (2013). Feline musculoskeletal pain index: Responsiveness and testing of criterion validity. Journal of Veterinary Internal Medicine, 27(3), 474-482.
-
- Deabold, K. A., Schwark, W. S., Wolf, L., & Wakshlag, J. J. (2019). Single-dose pharmacokinetics and preliminary safety assessment with use of CBD-rich hemp nutraceutical in healthy dogs and cats. Animals, 9(10), 832.
-
- Di Marzo, V., & Piscitelli, F. (2015). The endocannabinoid system and its modulation by phytocannabinoids. Neurotherapeutics, 12(4), 692-698.
-
- Epstein, M., Rodan, I., Griffenhagen, G., Kadrlik, J., Petty, M. C., Robertson, S. A., Simpson, W., AHAA, & AAFP. (2015). AAHA/AAFP pain management guidelines for dogs and cats. Journal of the American Animal Hospital Association, 51(2), 67-84.
-
- Klinck, M. P., Frank, D., Guillot, M., & Troncy, E. (2012). Owner-perceived signs and veterinary diagnosis in 50 cases of feline osteoarthritis. The Canadian Veterinary Journal, 53(11), 1181.
